Happy Doctor Group Submits IPO Prospectus: Pioneering China's First Andrology-Focused Physician Network with Internet-Enabled Standardized Care

“Male” Predicaments: A Growing Concern for a Vast Number of Chinese Men. VCBeat (WeChat ID: vcbeat) has learned that on March 28, the first andrology physician group in China, Happy Doctor Group, initiated by Chunyu Gangwan, was officially established in Beijing. The group aims to leverage internet healthcare models to provide private, standardized, and precise solutions for andrological issues. On the day of its establishment, Chunyu Gangwan jointly released the inaugural “White Paper on Internet-Based Andrology Diagnosis and Treatment in China” with VCBeat Eggshell Research Institute.

According to reports, Professor Li Yueqing, former President of Dongzhimen Hospital affiliated with Beijing University of Chinese Medicine, academic leader of the National Administration of Traditional Chinese Medicine’s key discipline “Andrology in Traditional Chinese Medicine,” and renowned Capital Master of Traditional Chinese Medicine, serves as Chief Medical Advisor of Happy Doctor Group. Researcher Li Rongsheng, former Director of the Experimental Pharmaceutical Factory of the China Academy of Chinese Medical Sciences, serves as Chief Pharmaceutical Advisor.

With socioeconomic development and increasingly fierce competition in living environments, people are under growing pressure from work and daily life. Coupled with environmental deterioration and changes in lifestyle, andrological diseases have become the third leading threat to men’s health.

According to data provided by the World Health Organization, the overall incidence rate of andrological diseases in China is 51%. Based on the population sample survey data from the "China Statistical Yearbook 2017," it is estimated that at least 361 million Chinese men currently suffer from varying degrees of andrological diseases.

Dean Li Yueqing pointed out that while the situation regarding andrological diseases is severe, the development of andrology has started later than gynecology, which has seen widespread conceptual popularization. In both the West and the East, modern andrology remains an emerging discipline. Therefore, despite more than a decade of construction and development yielding significant progress, the field still faces numerous serious challenges. For instance, most hospitals in China have not yet established dedicated andrology departments; instead, the diagnosis and treatment of male diseases are handled by urology departments. As a result, patients often need to seek care across multiple departments, including urology, dermatology, endocrinology, and traditional Chinese medicine.

As a field involving private health concerns, the internet has played a significant role in the advancement and development of andrology. Professor Waldinger, Chair of the Sexual Medicine Section of the European Psychiatric Association (EPA), hailed as the “Columbus of the Age of Discovery” in the realm of digital health, stated, “Even in Europe’s relatively open social environment, men are often still reluctant to discuss private issues ‘face-to-face.’”

He believes that the internet-based healthcare model aligns perfectly with andrology, enabling patients to access medical consultations conveniently and without burden. Chunyu Gangwan specializes in online andrology services, collaborating with renowned domestic and international experts to develop standardized diagnosis and treatment protocols. This approach not only ensures the quality of patient consultations but also lays the foundation for precision medicine and disease management.

The inaugural "White Paper on Internet-Based Andrology Diagnosis and Treatment in China," jointly released by Chunyu Gangwan and VCBeat’s Eggshell Research Institute, indicates that strong privacy protection and convenience constitute the core competitive advantages of online andrology services. Consequently, these services are widely favored by mainstream internet users, particularly those born in the 1980s and 1990s. The market is expanding rapidly, with key metrics such as unique visitors and paid consultation volumes experiencing robust growth.

Currently, Xingfu Doctor Group is the first and most prestigious physician group in the field of andrology, bringing together authoritative experts and physicians from both China and abroad. All members of its core Expert Advisory Committee are chief physicians with extensive experience in the diagnosis, treatment, and disciplinary development of andrological conditions.

Professor Deng Chunhua, Director of the Department of Andrology at The First Affiliated Hospital of Sun Yat-sen University, pointed out that Happy Doctor Group emerged on the foundation of standardized internet-based andrology diagnosis and treatment provided by Spring Rain Harbor. This organizational model empowers physicians through a centralized physician service system and Software-as-a-Service (SaaS) tools, expanding their service reach, enhancing their operational capabilities, and comprehensively assisting them in building credible brands, ultimately delivering the most valuable medical services to patients.

Liu Qian, founder of Unicorn Studio, also pointed out that internet-based andrology diagnosis and treatment platforms, represented by Chunyu Gangwan, have a massive user base and thus possess strong data collection capabilities. By anonymizing and digitizing the entire patient journey—including diagnosis, treatment, and medication—and conducting in-depth analysis and accumulation of this data, these platforms can establish a comprehensive medical feedback loop, laying a robust data foundation for future medical artificial intelligence.

Huang Yi, Founder of Xingfu Doctor Group and CEO of Chunyu Gangwan, stated, “Xingfu Doctor Group represents a commercial evolution for Chunyu Gangwan’s deep engagement in the internet-based andrology sector. It is committed to building a diversified medical service system that integrates ‘standardized diagnosis and treatment services, brand empowerment and output, technical and data support, and commercial supply chains.’ In the future, Xingfu Doctor Group will gradually establish a multi-tiered physician group system and a branded physician program. Leveraging cutting-edge technologies and innovative products, it will provide preventive, diagnostic, and therapeutic services for andrological diseases, while promoting academic exchanges in the field of andrology both domestically and internationally, thereby enhancing the standard of andrological diagnosis and treatment in China.”

It is understood that Chunyu Gangwan has also entered into contractual collaborations with several well-known manufacturers, leveraging centralized procurement to provide users with branded, quality-assured product supply services. During the conference, it also announced a strategic partnership with Guangyutang Guoyao. Both parties will align with the national strategy for the development of Traditional Chinese Medicine (TCM) by closely coordinating in the sales of Erxian Gao products and e-commerce marketing, jointly committed to promoting and advancing TCM in men’s health.